STAAR Surgical Co
Suletud
SektorTervishoid
26.26 -1.61
Ülevaade
Aktsiahinna muutus
24h
Min
26.12
Max
26.73
Sissetulek | -8.1M 5.6K |
|---|---|
Müük | -10M 83M |
P/E Sektori keskmine | 2,455 68.089 |
Aktsiakasum | 0.26 |
Kasumimarginaal | 0.007 |
Töötajad | 921 |
EBITDA | -14M 5.5K |
Soovitused | Osta |
|---|---|
12 kuu keskmine prognoos | +12.42% upside |
Turukapital | -18M 1.2B |
|---|---|
Eelmine avamishind | 27.87 |
Eelmine sulgemishind | 26.26 |
STAAR Surgical Co Graafik
Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.
Seotud uudised
Võrdlus sarnastega
Hinnamuutus
STAAR Surgical Co Prognoos
Hinnasiht
By TipRanks
12.42% tõus
12 kuu keskmine prognoos
Keskmine 29.667 USD 12.42%
Kõrge 34 USD
Madal 23 USD
Põhineb 3 Wall Streeti analüütiku instrumendi STAAR Surgical Co 12 kuu hinnasihil - viimase 3 kuu andmed.
Finantsandmed
Müügi- ja halduskulud
Tegevuskulud
Maksueelne kasum
Müük
Müügikulu
Brutokasum müügist
Intressikulud võla pealt
EBITDA
Ärikasum
$
Ettevõttest STAAR Surgical Co
STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia. It markets its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as products are primarily used by ophthalmologists. The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through own representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.